MADRIGAL PHARMACEUTICALS, INC. (MDGL) Shareholders’ equity 2017–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) shareholders’ equity at each fiscal year-end, per SEC filings.
$602.7MFY2025 · since FY2017: $182.3M → $602.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $602.7M | -20.1% |
| FY2024 | $754.4M | +86.1% |
| FY2023 | $405.3M | +105.3% |
| FY2022 | $197.4M | +0.7% |
| FY2021 | $196.1M | -18.3% |
| FY2020 | $240.0M | -42.4% |
| FY2019 | $416.6M | -12.7% |
| FY2018 | $477.0M | +161.7% |
| FY2017 | $182.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice